Health Law & Business

Leave Medicare Drug Coverage Alone, Patient Advocates Say

Nov. 29, 2018, 11:31 AM

Medicare’s system for ensuring that patients are able to get the specific medicine they need for certain chronic diseases is working, and the government should not tinker with it, a panel of patient advocates said.

Medicare plans that cover the prescriptions already have adequate tools to keep pharmaceutical prices contained, Catherine Finley, senior adviser for a coalition called the Partnership for Part D Access, said. She spoke during a Nov. 28 panel discussion on changes to the drug benefit proposed for 2020.

Insurers must cover substantially all medicines in six “protected classes” of drugs, but the Centers for Medicare &...

To read the full article log in. To learn more about a subscription click here.